O Rosen

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. pmc Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
    O Rosen
    Department of Oncology Haematology, University Hospital Charité Campus Mitte, Berlin, Germany
    Arthritis Res 2:327-36. 2000
  2. doi request reprint A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation
    C Lutz
    Department of Hematology and Oncology, Campus Virchow Klinikum, Berlin, Germany
    Bone Marrow Transplant 41:805-12. 2008
  3. ncbi request reprint Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy
    O Rosen
    Department of Oncology/Haematology, , Berlin, Germany
    Bone Marrow Transplant 27:657-8. 2001
  4. ncbi request reprint Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis
    G Massenkeil
    Department of Internal Medicine, Clinic for Nuclear Medicine and Institute of Radiology, , Berlin, Germany
    Leukemia 15:1701-5. 2001
  5. ncbi request reprint Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias
    G Massenkeil
    Department of Haematology and Oncology, Campus Virchow Klinikum, Charite University Medicine Berlin, Berlin, Germany
    Bone Marrow Transplant 36:683-9. 2005
  6. ncbi request reprint Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    G Massenkeil
    Dept of Internal Medicine, Division of Hematology and Oncology, University Hospital Charite, Campus Virchow Klinikum, Humboldt University, Berlin, Germany
    Bone Marrow Transplant 30:899-903. 2002
  7. ncbi request reprint Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study
    O Rosen
    Department of Haematology Oncology, Charite Campus Virchow, Berlin, Germany
    Br J Haematol 123:836-41. 2003

Collaborators

Detail Information

Publications7

  1. pmc Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
    O Rosen
    Department of Oncology Haematology, University Hospital Charité Campus Mitte, Berlin, Germany
    Arthritis Res 2:327-36. 2000
    ..Remissions persisted after reconstitution of the immune system. In the treatment of advanced systemic sclerosis (SSc), stable disease may be achieved with autologous SCT...
  2. doi request reprint A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation
    C Lutz
    Department of Hematology and Oncology, Campus Virchow Klinikum, Berlin, Germany
    Bone Marrow Transplant 41:805-12. 2008
    ..As the accompanying GVHD rate was considerable, careful selection of patients for prophylactic DLIs is mandatory...
  3. ncbi request reprint Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy
    O Rosen
    Department of Oncology/Haematology, , Berlin, Germany
    Bone Marrow Transplant 27:657-8. 2001
    ..We conclude that in selected patients with SSc, biopsies should be performed to reduce mortality after ASCT...
  4. ncbi request reprint Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis
    G Massenkeil
    Department of Internal Medicine, Clinic for Nuclear Medicine and Institute of Radiology, , Berlin, Germany
    Leukemia 15:1701-5. 2001
    ..Standard prophylactic measures are not sufficient to prevent loss of bone mass. Studies on prophylactic interventions are needed to prevent severe osteoporosis in long-term survivors of SCT...
  5. ncbi request reprint Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias
    G Massenkeil
    Department of Haematology and Oncology, Campus Virchow Klinikum, Charite University Medicine Berlin, Berlin, Germany
    Bone Marrow Transplant 36:683-9. 2005
    ..In retrospective analysis, patients with acute leukaemias who receive RIC because of contraindications against standard SCT have a comparable outcome to standard SCT, but the higher relapse rate warrants further studies...
  6. ncbi request reprint Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation
    G Massenkeil
    Dept of Internal Medicine, Division of Hematology and Oncology, University Hospital Charite, Campus Virchow Klinikum, Humboldt University, Berlin, Germany
    Bone Marrow Transplant 30:899-903. 2002
    ..This is the first report on the safety of basiliximab in patients with steroid-refractory acute GVHD. Our data suggest that basiliximab is effective in a substantial proportion of these patients...
  7. ncbi request reprint Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study
    O Rosen
    Department of Haematology Oncology, Charite Campus Virchow, Berlin, Germany
    Br J Haematol 123:836-41. 2003
    ..PEG-ASP was well tolerated. Despite the long half-life of PEG-ASP, neither pancreatic nor central nervous toxicities occurred among the 26 adult patients treated in this pilot study...